C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets

Author(s): Julia Vistbakka, Natalia VanDuyn, Garry Wong, Richard Nass

Journal Name: CNS & Neurological Disorders - Drug Targets
Formerly Current Drug Targets - CNS & Neurological Disorders

Volume 11 , Issue 8 , 2012

Become EABM
Become Reviewer
Call for Editor


Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms and the selective loss of dopaminergic neurons. The etiology of idiopathic PD is likely a combination of genetic and environmental factors. Despite findings from mammalian studies that have provided significant insight into the disorder, the molecular mechanisms underlying its pathophysiology are still poorly understood. The nematode Caenorhabditis elegans (C. elegans) is a powerful system for genetic analysis. Considering C. elegans short lifespan, fully sequenced genome, high genetic and neurobiochemical conservation with humans, as well as the availability of facile genetic tools, the nematode represents a highly efficient and effective model system to explore the molecular basis of PD. In this review we describe the utility of C. elegans for PD research, and the opportunity the model system presents to identify therapeutic targets.

Keywords: Nematode, dopamine, Parkinson’s disease, neurodegeneration, neuroprotection, dopaminergic neurons, mammalian studies, pathophysiology, Caenorhabditis, therapeutic targets.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 10 January, 2013
Page: [957 - 964]
Pages: 8
DOI: 10.2174/1871527311211080004
Price: $65

Article Metrics

PDF: 23